◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › H › HAE

Haemonetics Corporation (HAE) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-08-22

Haemonetics Corporation (HAE) operates in the MEDICAL DEVICES industry and is headquartered in Boston, United States with about 3,009 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2026-03-31, HAE reported $1.3B in revenue and $97M in net income.

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions. The company operates through Plasma, Blood Center, and Hospital segments.

Interactive charts & full statements → Open the HAE valuation workbench →

HAE Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Revenue	$1.4B	$1.3B	$1.4B	$1.3B	$1.2B	$993M	$870M	$988M	$968M	$904M	$886M	$909M	$910M	$939M	$892M	$728M	$677M	$645M	$598M	$516M	$450M
Gross Profit	$776M	$744M	$779M	$712M	$623M	$531M	$428M	$488M	$418M	$412M	$378M	$406M	$434M	$468M	$428M	$369M	$355M	$337M	$308M	$258M	$227M
Gross Margin %	57.4%	55.7%	57.2%	54.4%	53.3%	53.4%	49.2%	49.4%	43.1%	45.6%	42.7%	44.7%	47.7%	49.9%	48.0%	50.7%	52.5%	52.3%	51.5%	49.9%	50.6%
Operating Income (EBIT)	$246M	$241M	$222M	$165M	$156M	$81M	$90M	$103M	$84M	$56M	($19M)	($44M)	$41M	$47M	$56M	$89M	$111M	$83M	$86M	$70M	$63M
Operating Margin %	18.2%	18.1%	16.3%	12.6%	13.4%	8.1%	10.3%	10.5%	8.6%	6.2%	-2.2%	-4.8%	4.5%	5.0%	6.3%	12.2%	16.3%	12.9%	14.3%	13.6%	14.0%
Net Income	$96M	$97M	$168M	$118M	$115M	$43M	$79M	$77M	$55M	$46M	($26M)	($56M)	$17M	$35M	$39M	$67M	$80M	$58M	$59M	$52M	$49M
Net Margin %	7.1%	7.3%	12.3%	9.0%	9.9%	4.4%	9.1%	7.7%	5.7%	5.0%	-3.0%	-6.1%	1.9%	3.8%	4.3%	9.2%	11.8%	9.0%	9.9%	10.1%	10.9%
EBITDA	$261M	$312M	$356M	$295M	$252M	$192M	$184M	$258M	$193M	$153M	$123M	$129M	$127M	$129M	$125M	$139M	$158M	$125M	$122M	$101M	$101M
Earnings Per Share (EPS)	$2.05	$2.05	$3.31	$2.29	$2.24	$0.84	$1.55	$1.48	$1.04	$0.85	$-0.51	$-1.09	$0.32	$0.67	$0.74	$1.30	$1.56	$1.12	$1.13	$0.97	$0.89
Shares Outstanding (M)	46M	47M	51M	51M	51M	51M	51M	52M	53M	54M	52M	51M	52M	52M	52M	52M	51M	52M	52M	53M	55M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HAE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$339M	$346M	$339M	$327M	$321M	$331M	$349M	$346M
Gross Profit	$203M	$198M	$191M	$183M	$192M	$182M	$200M	$191M
Gross Margin %	59.8%	57.2%	56.5%	56.0%	59.7%	55.0%	57.4%	55.3%
Operating Income (EBIT)	$57M	$51M	$70M	$67M	$54M	$51M	$59M	$52M
Operating Margin %	16.9%	14.8%	20.5%	20.5%	16.8%	15.6%	16.9%	15.0%
Net Income	$33M	($20M)	$45M	$39M	$34M	$58M	$37M	$34M
Net Margin %	9.7%	-5.8%	13.2%	11.8%	10.6%	17.5%	10.8%	9.8%
EBITDA	$75M	$4M	$95M	$87M	$94M	$99M	$95M	$89M
Earnings Per Share (EPS)	$0.72	$-0.44	$0.95	$0.81	$0.70	$1.17	$0.74	$0.66
Shares Outstanding (M)	46M	46M	47M	48M	48M	49M	51M	51M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HAE Free Cash Flow History

Cash flow	TTM → 2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Cash from Operations (CFO)	$328M	$293M	$182M	$182M	$273M	$172M	$109M	$158M	$159M	$220M	$160M	$122M	$127M	$140M	$85M	$115M	$123M	$131M	$116M	$78M	$84M
Capital Expenditures (CapEx)	$37M	$33M	$39M	$38M	$110M	$97M	$37M	$49M	$119M	$75M	$76M	$102M	$122M	$74M	$62M	$53M	$47M	$56M	$56M	$58M	$41M
Free Cash Flow (FCF)	$291M	$260M	$142M	$144M	$163M	$76M	$72M	$109M	$40M	$146M	$84M	$19M	$5M	$66M	$23M	$62M	$77M	$74M	$60M	$20M	$42M
FCF Margin %	21.5%	19.5%	10.5%	11.0%	13.9%	7.6%	8.2%	11.1%	4.2%	16.1%	9.4%	2.1%	0.5%	7.0%	2.6%	8.5%	11.3%	11.5%	10.0%	3.9%	9.4%
Dividends Paid	—	—	—	—	$7M	—	—	$12M	$13M	$0M	$0M	$0M	$0M	$0M	$0M	$15M	$0M	—	—	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HAE Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$52M	$71M	$94M	$111M	$17M	$117M	$44M	$49M
Capital Expenditures (CapEx)	$8M	$18M	$6M	$5M	$4M	$16M	$9M	$9M
Free Cash Flow (FCF)	$44M	$53M	$87M	$106M	$14M	$101M	$35M	$39M
FCF Margin %	13.1%	15.4%	25.7%	32.5%	4.2%	30.5%	10.1%	11.4%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

HAE Balance Sheet History

Balance sheet	2026-06-30	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Assets	$2.4B	$2.4B	$2.5B	$2.2B	$1.9B	$1.9B	$1.8B	$1.3B	$1.3B	$1.2B	$1.2B	$1.3B	$1.5B	$1.5B	$1.5B	$911M	$833M	$754M	$650M	$609M	$573M
Cash & Cash Equivalents	$223M	$245M	$307M	$179M	$284M	$259M	$192M	$137M	$169M	$180M	$140M	$115M	$161M	$192M	$179M	$229M	$197M	$142M	$157M	$134M	$229M
Total Liabilities	$1.5B	$1.6B	$1.6B	$1.2B	$1.1B	$1.1B	$1.1B	$680M	$607M	$485M	$499M	$597M	$657M	$681M	$693M	$176M	$147M	$161M	$110M	$115M	$93M
Total Debt (Short + Long-Term)	$1.2B	$1.2B	$1.2B	$808M	$766M	$781M	$715M	$390M	$350M	$254M	$315M	$408M	$428M	$438M	$480M	$4M	$5M	$21M	$6M	$12M	$29M
Total Shareholders' Equity	$837M	$796M	$821M	$960M	$818M	$749M	$732M	$587M	$668M	$752M	$740M	$720M	$826M	$840M	$769M	$735M	$686M	$593M	$540M	$494M	$480M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HAE viewer.

Other Companies in MEDICAL DEVICES

GMED · Globus Medical — $10 billion
BIO.B · Bio-Rad Laboratories Inc — $10 billion
GKOS · Glaukos Corp — $10 billion
BRKR · Bruker Corporation — $9 billion
ITGR · Integer Holdings Corp — $4 billion
LIVN · LivaNova PLC — $4 billion
IRTC · iRhythm Technologies Inc — $4 billion
TMDX · TransMedics Group Inc — $3 billion

← HACQ All “H” companies HAFC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.